← Eichor
Study identifier: NCT02638701 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

Condition: Aneurysm · Stroke · Vasculitis  ·  Sponsor: University of California, San Francisco

PhasePhase 1/Phase 2
Planned participants8
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for development of medical therapy for DVB aneurysms

This description comes directly from the study's public registry record.

Talk to the study team

Daniel L Cooke, MD  ·  415-353-1863  ·  daniel.cooke@ucsf.edu

Atakan Orscelik, MD  ·  415-353-7500  ·  atakan.orscelik@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UCSF Medical CenterSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02638701